Cerus

Cerus company information, Employees & Contact Information

Explore related pages

Related company profiles:

Cerus Corporation is dedicated solely to safeguarding the world’s blood supply and aims to become the preeminent global blood products company. Headquartered in Concord, California, the company develops and supplies vital technologies and pathogen-protected blood components to blood centers, hospitals, and ultimately patients who rely on safe blood. The INTERCEPT Blood System for platelets and plasma is available globally and remains the only pathogen reduction system with both CE mark and FDA approval for these two blood components. In the US, the INTERCEPT Blood System for Cryoprecipitation is approved for the production of Pathogen Reduced Cryoprecipitated Fibrinogen Complex (commonly referred to as INTERCEPT Fibrinogen Complex), a therapeutic product for the treatment and control of bleeding, including massive hemorrhage, associated with fibrinogen deficiency. The INTERCEPT red blood cell system is in late-stage clinical development. For more information about Cerus, visit www.cerus.com and follow us on LinkedIn.

Company Details

Employees
384
Founded
-
Address
1220 Concord Ave, Suite 600,netherlands
Phone
9252886001
Industry
Biotechnology Research
NAICS
Research and Development in Biotechnology (except Nanobiotechnology)
Website
cerus.com
HQ
Concord, California
Looking for a particular Cerus employee's phone or email?

Cerus Questions

News

Cerus Corporation to Release Third Quarter 2025 Financial Results on November 6, 2025 - Business Wire

Cerus Corporation to Release Third Quarter 2025 Financial Results on November 6, 2025 Business Wire

Cerus Corporation Announces Second Quarter 2025 Financial Results - Yahoo Finance

Cerus Corporation Announces Second Quarter 2025 Financial Results Yahoo Finance

Cerus Hits Major Milestone: INTERCEPT Blood System Expands to All Patient Indications in EU Review - Stock Titan

Cerus Hits Major Milestone: INTERCEPT Blood System Expands to All Patient Indications in EU Review Stock Titan

Cerus Corporation Announces Abstracts and Industry Workshop on IFC at the 2025 AABB Annual Meeting - Business Wire

Cerus Corporation Announces Abstracts and Industry Workshop on IFC at the 2025 AABB Annual Meeting Business Wire

Cerus Corporation Announces Additional Department of Defense Award to Advance Care for Major Hemorrhage in Traumatic Injury - Yahoo Finance

Cerus Corporation Announces Additional Department of Defense Award to Advance Care for Major Hemorrhage in Traumatic Injury Yahoo Finance

The German National Blood Advisory Committee Issues Formal Recommendation for Improving the Safety of Platelet Transfusions - Yahoo Finance

The German National Blood Advisory Committee Issues Formal Recommendation for Improving the Safety of Platelet Transfusions Yahoo Finance

Cerus stock rating reiterated by BTIG, citing strong Q2 results - Investing.com

Cerus stock rating reiterated by BTIG, citing strong Q2 results Investing.com

'Reimagine the saxophone': Get to know the Cerus Quartet - Interlochen Public Radio

'Reimagine the saxophone': Get to know the Cerus Quartet Interlochen Public Radio

Cerus Corporation (NASDAQ:CERS) Stock Rockets 26% But Many Are Still Ignoring The Company - simplywall.st

Cerus Corporation (NASDAQ:CERS) Stock Rockets 26% But Many Are Still Ignoring The Company simplywall.st

Cerus Corporation Celebrates World Blood Donor Day 2025 - Yahoo Finance

Cerus Corporation Celebrates World Blood Donor Day 2025 Yahoo Finance

Cerus Corporation Announces Preliminary Fourth Quarter and Full-Year 2024 Product Revenue and Provides Business Update - BioSpace

Cerus Corporation Announces Preliminary Fourth Quarter and Full-Year 2024 Product Revenue and Provides Business Update BioSpace

The Cerus Quartet plants their award-winning sounds in IPR's Sound Garden Project - Interlochen Public Radio

The Cerus Quartet plants their award-winning sounds in IPR's Sound Garden Project Interlochen Public Radio

When Should You Buy Cerus Corporation (NASDAQ:CERS)? - Yahoo Finance

When Should You Buy Cerus Corporation (NASDAQ:CERS)? Yahoo Finance

Cerus And 2 Other Promising Penny Stocks To Watch - Yahoo Finance

Cerus And 2 Other Promising Penny Stocks To Watch Yahoo Finance

With 64% ownership, Cerus Corporation (NASDAQ:CERS) boasts of strong institutional backing - Yahoo Finance

With 64% ownership, Cerus Corporation (NASDAQ:CERS) boasts of strong institutional backing Yahoo Finance

Cerus (NASDAQ:CERS) shareholders have endured a 80% loss from investing in the stock five years ago - Yahoo Finance

Cerus (NASDAQ:CERS) shareholders have endured a 80% loss from investing in the stock five years ago Yahoo Finance

Cerus Leads Our Selection Of 3 Promising Penny Stocks - Yahoo Finance

Cerus Leads Our Selection Of 3 Promising Penny Stocks Yahoo Finance

Cerus Corporation (NASDAQ:CERS) Just Reported And Analysts Have Been Cutting Their Estimates - simplywall.st

Cerus Corporation (NASDAQ:CERS) Just Reported And Analysts Have Been Cutting Their Estimates simplywall.st

After losing 21% in the past year, Cerus Corporation (NASDAQ:CERS) institutional owners must be relieved by the recent gain - simplywall.st

After losing 21% in the past year, Cerus Corporation (NASDAQ:CERS) institutional owners must be relieved by the recent gain simplywall.st

Cerus Corporation Reports Strong Q2 2025 Revenue Growth - TipRanks

Cerus Corporation Reports Strong Q2 2025 Revenue Growth TipRanks

Cerus Q4 2024 slides: Positive EBITDA achieved amid 15% revenue growth - Investing.com

Cerus Q4 2024 slides: Positive EBITDA achieved amid 15% revenue growth Investing.com

Insiders Sold Cerus Prematurely At US$1.64 With Stock Trading Higher - simplywall.st

Insiders Sold Cerus Prematurely At US$1.64 With Stock Trading Higher simplywall.st

Cerus Secures More DoD Funding To Improve Trauma Hemorrhage Care - Pulse 2.0

Cerus Secures More DoD Funding To Improve Trauma Hemorrhage Care Pulse 2.0

Antibody profiles in COVID-19 convalescent plasma prepared with amotosalen/UVA pathogen reduction treatment - Wiley Online Library

Antibody profiles in COVID-19 convalescent plasma prepared with amotosalen/UVA pathogen reduction treatment Wiley Online Library

Cerus Markets Review 2025 - Investing.com

Cerus Markets Review 2025 Investing.com

Robust inactivation of Plasmodium falciparum in red blood cell concentrates using amustaline and glutathione pathogen reduction - Wiley Online Library

Robust inactivation of Plasmodium falciparum in red blood cell concentrates using amustaline and glutathione pathogen reduction Wiley Online Library

Stryker completes acquisition of Cerus Endovascular - MassDevice

Stryker completes acquisition of Cerus Endovascular MassDevice

US Biotech Cerus appoints Alicia Goodman as CHRO - People Matters Global

US Biotech Cerus appoints Alicia Goodman as CHRO People Matters Global

Latest data reinforce evidence on safety and effectiveness of Contour intra-aneurysmal flow diverter - NeuroNews International

Latest data reinforce evidence on safety and effectiveness of Contour intra-aneurysmal flow diverter NeuroNews International

Stryker completes acquisition of Cerus Endovascular - PR Newswire

Stryker completes acquisition of Cerus Endovascular PR Newswire

Cerus Endovascular Breaks Through the Competition with New Designation - Medical Device and Diagnostic industry

Cerus Endovascular Breaks Through the Competition with New Designation Medical Device and Diagnostic industry

US FDA grants approval for Cerus’ INTERCEPT blood system - Medical Device Network

US FDA grants approval for Cerus’ INTERCEPT blood system Medical Device Network

Stryker completes acquisition of Cerus Endovascular - NeuroNews International

Stryker completes acquisition of Cerus Endovascular NeuroNews International

Inactivation of chikungunya virus in blood components treated with amotosalen/ultraviolet A light or amustaline/glutathione - Wiley Online Library

Inactivation of chikungunya virus in blood components treated with amotosalen/ultraviolet A light or amustaline/glutathione Wiley Online Library

Cerus Corporation (CERS) Q1 2021 Earnings Call Transcript - The Motley Fool

Cerus Corporation (CERS) Q1 2021 Earnings Call Transcript The Motley Fool

CERUS Announces the Acquisition of Laboratori Derivati Organici SpA (LDO) by Opocrin SpA - BioSpace

CERUS Announces the Acquisition of Laboratori Derivati Organici SpA (LDO) by Opocrin SpA BioSpace

Cerus Markets launches MT5 - FX News Group

Cerus Markets launches MT5 FX News Group

Cerus Endovascular receives CE mark approval for its Contour Neurovascular System to treat intracranial aneurysms - NeuroNews International

Cerus Endovascular receives CE mark approval for its Contour Neurovascular System to treat intracranial aneurysms NeuroNews International

First patients enrolled in CERUS study to treat intracranial aneurysms using Contour Neurovascular System to reduce the risk of rupture - NeuroNews International

First patients enrolled in CERUS study to treat intracranial aneurysms using Contour Neurovascular System to reduce the risk of rupture NeuroNews International

Top Cerus Employees

Free Chrome Extension

Find emails, phones & company data instantly

Find verified emails from LinkedIn profiles
Get direct phone numbers & mobile contacts
Access company data & employee information
Works directly on LinkedIn - no copy/paste needed
Get Chrome Extension - Free

Aero Online

Your AI prospecting assistant